
111. Highlights from the SPD! - Ritlecitinib in adolescents with alopecia areata - UBA1 Variants Associated With VEXAS Syndrome - Role of Soluble IL-2 Receptor in Health & Disease - Botox for HA
111. Highlights from the SPD! - Ritlecitinib in adolescents with alopecia areata - UBA1 Variants Associated With VEXAS Syndrome - Role of Soluble IL-2 Receptor in Health & Disease - Botox for HA
Highlights from the SPD! - Ritlecitinib in adolescents with alopecia areata - UBA1 Variants Associated With VEXAS Syndr... Read more
7 Aug 2023
•
1hr 14mins

110. Most Published Findings are False - with Wtatistician Phil Watkins! - Menopause and Derm - part 3 - Dermasphere Clip Show: Episodes 101-110!
110. Most Published Findings are False - with Wtatistician Phil Watkins! - Menopause and Derm - part 3 - Dermasphere Clip Show: Episodes 101-110!
Most published findings are false - with statistician Phil Watkins! - Menopause and derm - part 3 - Dermasphere clip sho... Read more
24 Jul 2023
•
1hr 12mins
Similar Podcasts

109. Plasma cells and derm with Dr. Alicia Schnebelen - Subcutaneous fat necrosis of the newborn - Lenabasum: A cannabinoid for dermatomyositis - Botulinum toxin for Hailey-Hailey and Darier's disease
109. Plasma cells and derm with Dr. Alicia Schnebelen - Subcutaneous fat necrosis of the newborn - Lenabasum: A cannabinoid for dermatomyositis - Botulinum toxin for Hailey-Hailey and Darier's disease
Plasma cells and derm with Dr. Alicia Schnebelen - Subcutaneous fat necrosis of the newborn - Lenabasum: A cannabinoid ... Read more
10 Jul 2023
•
1hr 1min

108. Steve Feldman on THE DEFAULT OPTION - TMP/SMX and ARDS - Tame the EHR inbox - Menopause and derm: Part 2 - Dupi -> less ADHD
108. Steve Feldman on THE DEFAULT OPTION - TMP/SMX and ARDS - Tame the EHR inbox - Menopause and derm: Part 2 - Dupi -> less ADHD
Steve Feldman on THE DEFAULT OPTION - TMP/SMX and ARDS - Tame the EHR inbox - Menopause and derm: Part 2 - Dupi -> le... Read more
26 Jun 2023
•
1hr 1min

107. Resistant tinea from T. indotineae - Bicalutamide for androgenetic alopecia - Pulse-dose steroids in pediatric AA - Menopause and derm - Costello syndrome: Don't treat for HPV! - Dr. Feldman
107. Resistant tinea from T. indotineae - Bicalutamide for androgenetic alopecia - Pulse-dose steroids in pediatric AA - Menopause and derm - Costello syndrome: Don't treat for HPV! - Dr. Feldman
Resistant tinea from T. indotineae - Bicalutamide for androgenetic alopecia - Pulse-dose steroids in pediatric AA - Meno... Read more
12 Jun 2023
•
59mins

106. Dr. Feldman on SALIENCE - Cemiplimab for SCCs - When dupi doesn't work - Digital minimalism in medicine - Malignant and premalignant oral lesions
106. Dr. Feldman on SALIENCE - Cemiplimab for SCCs - When dupi doesn't work - Digital minimalism in medicine - Malignant and premalignant oral lesions
Dr. Feldman on SALIENCE - Cemiplimab for SCCs - When dupi doesn't work - Digital minimalism in medicine - Malignant and ... Read more
29 May 2023
•
1hr 1min

105. A20 Haploinsufficiency - Difelikefalin in CKD - Difelikifalin Safety - Limiting Acne Abx
105. A20 Haploinsufficiency - Difelikefalin in CKD - Difelikifalin Safety - Limiting Acne Abx
A20 haploinsufficiency - Difelikefalin for pruritus in CKD - efficacy - Difelikifalin safety - Limiting systemic antibio... Read more
15 May 2023
•
1hr 6mins

104. Biologics for guttate psoriasis - Secukinumab for HS - Perialar intertrigo - Acne-Associated Angiofibroma-like Papules - New melasma treatments
104. Biologics for guttate psoriasis - Secukinumab for HS - Perialar intertrigo - Acne-Associated Angiofibroma-like Papules - New melasma treatments
Biologics for guttate psoriasis - Secukinumab for HS - Perialar intertrigo - Acne-associated angiofibroma-like papules -... Read more
1 May 2023
•
1hr 12mins

103. ACD with Jeff Yu! - AAD highlights - Nicotinamide doesn't work in txp pts - Spinosad for scabies
103. ACD with Jeff Yu! - AAD highlights - Nicotinamide doesn't work in txp pts - Spinosad for scabies
ACD with Jeff Yu! - AAD highlights - Nicotinamide doesn't work in txp pts - Spinosad for scabies Find Jeff Yu on Twit... Read more
17 Apr 2023
•
1hr 8mins

102. The palm is ~0.5% TBSA - Insurance companies denying coverage - Malignancy risk in JAK inhibitors - MACE risk in JAK inhibitors - Oral azoles for head-and-neck dermatitis
102. The palm is ~0.5% TBSA - Insurance companies denying coverage - Malignancy risk in JAK inhibitors - MACE risk in JAK inhibitors - Oral azoles for head-and-neck dermatitis
The palm is ~0.5% TBSA - Insurance companies denying coverage - Malignancy risk in JAK inhibitors - MACE risk in JAK inh... Read more
3 Apr 2023
•
1hr